Skip to main content

Table 1 Pituitary adenoma stem cell patient isolates: Clinico-pathological data

From: The identification of human pituitary adenoma-initiating cells

Sample ID Gender Age Adenoma Subtype CD15% CD133% Sox2%
PA1 M 69 GH 15.92 1.82 3.55
PA2 M 72 ACTH 10.25 89.75 12.82
PA3 M 35 GH 75.15 1.2 9.53
PA4 F 66 FSH/LH 83.46 16.55 4.54
PA5 M 76 GH 7.12 0.54 3.11
PA6 M 53 FSH/PRL 4.11 23.13 11.35
PA7 F 26 GH/PRL 2.59 47.98 28.36
PA8 F 52 Null Cell 62.71 1.07 2.24
PA9 F 76 LH 4.51 13.11 9.23
PA10 F 60 Null Cell 80.72 19.29 2.74
PA11 M 80 Null Cell 84.22 1.99 2.05
PA12 M 83 Null Cell 14.98 11.32 4.52
PA13 M 80 Null Cell 72.70 1.52 2.74
PA14 M 48 GH/PRL 7.06 3.92 6.63
PA15 M 51 GH/PRL 3.11 1.42 3.13
PA16 M 70 Null Cell 53.12 0.45 1.19
PA17 M 42 GH 99.56 0.47 19.24
PA18 M 64 Null Cell 7.23 12.21 7.31
PA19 M 52 Null Cell 98.86 0.96 15.07
PA20 M 72 GH 9.86 2.26 1.78
PA21 F 71 Null Cell 62.12 1.11 1.42
PA22 F 71 Null Cell 44.15 1.78 2.51
  1. PA pituitary adenoma, M Male, F Female, GH Growth Hormone, ACTH Adrenocorticotropic Hormone, PRL Prolactin, FSH Follicle-Stimulating Hormone, LH Luteinizing Hormone